Sciatic nerve injury can cause differential expression of microRNAs in dorsal root ganglia

Slit-Robo GTPase-activating protein 3 contains a Rho GAP domain that regulates the activities of Rho family GTPases and affects actin polymerization, which influences dendrite elaboration, neurite outgrowth and axon guidance, contributing to neural regeneration.

Anjie Lu, the Third Xiangya Hospital of Central South University, China and his team performed a microRNA microarray analysis and identified 23 microRNAs whose expression were significantly changed in rat dorsal root ganglia (DRG) after sciatic nerve injury (SNI). Bioinformatic analysis was used to determine microRNA-214 took srGAP3 as possible target gene and most correlated with axon guidance pathway. Quantitative reverse transcriptase-PCR and dual-luciferase reporter gene assay further confirmed the targeting relationship between microRNA-214 and srGAP3. In situ hybridization, western blot and immunofluorescence staining showed that microRNA-214 expression in rat DRG was decreased, while srGAP3 protein expression was gradually increased at 1-7 days after SNI.

The results indicate that SNI can cause the differential expression of microRNAs in DRG primary neurons in lumbar segment, srGAP3 is a target gene of microRNA-214, and there is a reverse relationship between microRNA-214 and srGAP3 expression. Related results were published in Neural Regeneration Research (Vol. 9, No. 10, 2014).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nogo-A inhibition demonstrates potential for spinal cord injury recovery